Archive - May 2018


Algomedix Inc. Announces Issuance of U.S. Patent for Novel TRPA1 Modulators Designed to Treat Chronic Pain as Alternatives to Addictive Opioids

MILL CREEK, Wash.–(BUSINESS WIRE)–Algomedix Inc., a biotech company developing first-in-class non-opioid pain medicines, today announced the U.S. Patent and Trademark Office has issued US Patent No. 9,951,046 covering the company‚Äôs novel, small molecule modulators of TRPA1 as well as compositions and methods for treating pain that include the compounds. The patent has a term extending to nearly 2036.

Read More